AccuDial Appoints distributor for Middle East and North Africa

AccuDial Pharmaceutical, Inc. and BroadMed S.A.L, with headquarters in Beirut, Lebanon signed an agreement for BroadMed to distribute Children's AccuDial analgesic, allergy, cough and cold medications.

BroadMed will distribute the AccuDial® brand in seventeen countries in the Middle East and North Africa.

“The demand for quality over-the-counter medication crosses all boarders and AccuDial's® weight-based dosing is the most accurate way to calculate and administer those medications,” said Robert Terwilliger, Chairman and CEO of AccuDial® Pharmaceutical, Inc. “This opens up a market that is 50% larger than the United States. The population of these two regions is 460 million people with 140 million being children. That's more than twice the number of children in the United States.”

“BroadMed is very happy to be able to offer Children's AccuDial® directly to our wholesalers and retailers,” adds BroadMed's Chairman and General Partner Khalil Asch, M.D. “Children's AccuDial® is the only medication that provides weight-based dosing that addresses the need to properly dosing our children.”

The distribution agreement is an exclusive in selected territories. Both companies are looking forward to broadening the reach of weight-based dosing for children. Children's AccuDial® features a revolutionary, two-part, patented label system that is only available on AccuDial medications. A parent or caregiver rotates the label until their child's weight appears in the viewing window. Below the child's weight is the proper amount of medication. A caregiver then pours the liquid into the calibrated dosing spoon (included in the package) to the exact measurement, and the child receives the correct dose of medication. No second guessing; it's all medical science!
Companies in this article
More in Home